We are pleased to announce that Matt Golembeski has joined the team at SmartTRAK as Director of Sales. Matt has 15+ of sales and sales management experience in the medical device industry with a concentration in spine and spine-supportive technologies.
Thomas Wallick
Recent Posts
3 min read
Meet Tim Patrick - Senior Manager of Corporate Accounts
We are pleased to announce that Tim Patrick has joined the team at SmartTRAK as Senior Manager of Corporate Accounts. Tim has 5+ years experience in Medical Device Sales and Healthcare IT. Tim had prior roles at Zimmer Biomet and Abbott Laboratories.
Meet Tim Patrick:
What is your role with SmartTRAK? I’ve joined the commercial team as a Senior Manager of Corporate Accounts.
What do you like about SmartTRAK? It’s tough to keep this question to a paragraph, but I will do my best! The space, product and people are what really intrigues me about SmartTRAK. The Medtech/Software space is ever changing and as dynamic of a space that I’ve been involved with. The product is absolutely incredible. The type of data we provide at your fingertips is a must have. Lastly, I’ve come from large Fortune 500 companies who have claimed to be a tight knit team but nothing compares to what we currently have at SmartTRAK. From the other reps, analysts, and up to the CEO it truly is the best culture I have ever been a part of.
Topics:
SmartTRAK News
Continue Reading
8 min read
Trials, Patents, Products & Predictions: The Week in Orthopedics
Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.
The following is just a small sampling of the Orthopedic updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry.
Early Major Revisions w/ Anterior Approach THA
An Australian joint registry data study w/ > 122K pTHAs found while there was no difference in overall cumulative % revision between surgical approaches, the anterior approach had a higher rate of major revisions w/ lower dislocation and infection rates. J Bone Joint Surg Am
SI Joint Fusion Market
Needham expects a higher physician payment for minimally invasive SI joint fusion procedures to be a steady tailwind for market expansion going into 2021.
Total Ankle Arthroplasty Safer than Total Hip/Knee
A study of pts in the National Surgical Quality Improvement Program from 2006 to 2016 found total ankle replacement had a lower complication rate (2.98%) compared to total hip (4.92%) and total knee (4.56%) in the early post-op period. J Am Acad Orthop Surg
Topics:
Orthopedics
Continue Reading
8 min read
SmartTRAK Trauma Market Updates: A COVID-19 Recovery on the Horizon?
Although COVID-19 has disrupted the medical device market, with many elective procedures being postponed, SmartTRAK anticipates the Trauma market to recover in 2021 and beyond. We anticipate that US Trauma fracture fixation procedures will be only slighted impacted by COVID-19, resulting in nearly flat YoY growth from 2019 to 2020 and believe that 2021 procedures will return to normal. This will result in 2021 procedural growth rates being inflated at ~10% and 2022 experiencing normal growth trends as volumes begin to stabilize.
The following is just a small sampling of the Trauma market updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, financial data and competitor developments in the global Life Sciences industry.
Intramedullary Device w/ a Guided Growth System
A US Patent “Intramedullary device” was granted to Sydney Children’s Hospitals Network of New South Wales, AU, describing a device system & method for providing stabilization of a bone & configured to allow extension of the device w/ the growth of the bone. 10,736,674
Ilizarov Method for Nonunion of the Tibia
Union was achieved at mean length of 8.3 mos in all 102 pts w/ tibial nonunion treated w/ an Ilizarov ex fix w/ 95.1% maintaining union at least 2 yrs post treatment leading a study to conclude the Ilizarov method is an excellent long-term option. Arch Orthop Trauma Surg
Inverted or Non-Inverted Triangle Configuration for Femoral Neck Fxs
A non-inverted triangular configuration of 6.5mm screws used in the fixation of femoral neck fxs carries a higher risk of bony violation than an inverted triangle configuration concluded a study of 72 cases. J Clin Orthop Trauma
Topics:
Orthopedics
COVID-19
Continue Reading
10 min read
MedTech Innovation in the Time of COVID
Despite the unprecedented challenges of the ongoing pandemic, and the collateral economic hit taken due to the massive decline in elective procedures in Q220, MedTech companies continue to innovate and introduce new products to the global life sciences industry.
The following is just a small sampling of the new products updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, financial data and competitor developments in the global Life Sciences industry.
Alphatec
*
In Q220, Alphatec commenced upgrades of its cervical portfolio with 510(k) clearance of the Insignia Anterior Cervical Plate System and InVictus CT Spinal Fixation System, which expands InVictus across cervical, thoracic and lumbar procedures.
GMED has launched 6 new products in 2020 w/ strong uptake of HEDRON 3D printed IBD spacers as well as SABLE expandable MIS TLIF device. Globus is doubling its 3D manufacturing capacity which should come online in Q4. GMED Q220 Earnings Transcript on Seeking Alpha
Alpha launches for COHERE TLIF O and TLIF A are slated for 2020, expanding the Company’s proprietary porous PEEK platform. NUVA Q220 Earnings Transcript on Seeking Alpha
Topics:
COVID-19
Continue Reading
8 min read
International MedTech News Updates: The Week in Review
The unprecedented challenges from the current resurgence of COVID-19 cases worldwide continues to concern the MedTech industry as it strives to develop ways to deal with a post-pandemic world. Despite the struggling global economy, demand for innovative medical devices and advanced technologies will continue to drive long term growth.
The following is just a small sampling of the updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
June in Russia
In the pharmacies in Russia, commercial drug June sales increased by 0.1% in value vs May 2020. Compared to June 2019, sales increased by 2.1%. The increase in the first 6 mos in 2020 was 13.9% vs the same period in 2019.
Teleconsultation in France
During the lockdown in April, 27% of all consultations were teleconsultations in France. Of doctors carrying out teleconsultations, 50% were under 50 yrs old, though that age group represents only 37% of all GPs.
MedTech World in Germany
MedTech companies in Germany expect sales to decline an avg of 8% in 2020 due to the pandemic, including 12% in int’l business according to a survey. Almost 60% of companies expect a double-digit drop.
Topics:
SmartTRAK News
COVID-19
Continue Reading
5 min read
SAWC Spring 2020 Goes Virtual: The Week In Wound Care
As the COVID-19 continues to affect every aspect of life, the MedTech industry perseveres in its attempt to adapt and continue moving forward. SAWC and the Wound Healing Society held the SAWC Spring 2020 as a virtual experience on July 24-26. In their words "At a time when so much else is canceled, the work to treat, manage, and prevent chronic wounds and improve patient care cannot stop. Hope must go on."
The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts, including many from SAWC 2020. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
COVID-19 and Chronic Wound Patients
Dr. Margaret A Liu, an expert in vaccines and immunotherapies, provided an excellent presentation on the intersection of vaccine technologies for COVID-19, disease pathology for pts w/ chronic wounds, and how it fits together with a global pandemic. SAWC 2020 Virtual
Topics:
Wound Care
Continue Reading
3 min read
SmartTRAK Analysts Featured in Cartilage.org ICRS Newsletter
SmartTRAK, the leading source of competitive intelligence used by the top global orthopedic & wound care companies, had four articles featured in the International Cartilage Regeneration & Joint Preservation Society Summer 2020 Issue. These articles were originally published on the SmartTRAK platform.
The ICRS is the main forum for international collaboration in cartilaginous tissue research and joint preservation whose stated mission is "Advancing Science & Education of the Prevention & Treatment of Cartilage Disease Worldwide."
Kim French, SmartTRAK's Senior Analyst, OrthoBio, had three of her articles included in the Summer 2020 issue:
Topics:
SmartTRAK News
Continue Reading
8 min read
Recovery Predictions, Elective Surgery and Future Outbreaks: COVID-19 Updates
As the COVID-19 pandemic progresses and continues to affect everyday life around the world, the path that lies ahead for the MedTech industry and the search for effective therapeutics and vaccines remains hard to predict.
The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
SVBLeerink Expects Q2 Recovery to Exceed Expectations
Based on prelim Q220 MedTech Company results, SVB Leerink expects May/June COVID recovery to exceed expectations noting elective procedure shutdowns are regionalized and halts are not expected to be as bad or prolonged as in March/April. SVBLeerink Medical Supplies and Devices
Based on prelim Q220 MedTech Company results, SVB Leerink expects May/June COVID recovery to exceed expectations noting elective procedure shutdowns are regionalized and halts are not expected to be as bad or prolonged as in March/April. SVBLeerink Medical Supplies and Devices
Positive COVID-19 Vaccine Data Could Fuel Medtech Sectors
With 4 of the leading vaccine candidates expected to enter Phase 3 studies in July (Sinovac, Moderna, BioNTech/PFE, CanSino), Phase 2 data could be reported in summer/fall 2020. If +, WFS says it could be a catalyst for some medtech sectors in recovery of elective procedures.
Public Perception of Resuming Elective Surgery
A survey assessing public perceptions towards resuming elective surg found out of 722 people 61% were concerned w/ contracting COVID-19 during surg. Overall, 57% would have surgery at a hospital vs outpatient and 27% would undergo surg in the first mo of reopening. J Arthroplasty
Preparation for Future Outbreaks
The European Commission published a document about the preparedness of health systems in Europe for future COVID-19 outbreaks. Topics comprise testing, contact tracing, surveillance, accessibility of medical devices and capacity measures.
Topics:
SmartTRAK News
COVID-19
Continue Reading
9 min read
Novel Ideas, New Products and Innovative Studies: The Week in OrthoBio
The orthobiologics market continues to ramp up studies and new product development as surgeries impacted by COVID-19 are rescheduled. The following is a small sampling of the OrthoBio updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
KAPPA Opiod - Possible DMOAD?
KECK Medicine of USC has published a preclinical study demonstrating the potential of a new opioid medication that may slow OA progression while being less addictive. The therapy MOA is kappa opioid receptor (KOR) modulation via inhibition of hedgehog signaling. Arthritis Rheum
Association of SNPs in MMPs Genes and Knee OA
A 200-pt prospective, case-control study is underway to assess if the presence of gene polymorphisms (1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13) in the metalloproteinases (MMPs) affect the risk of developing idiopathic kOA in the Greek population. clinicaltrials.gov
National Rates and Risk Factors of Failed Primary RCR
An insurance database review w/ 41,467 primary RCR pts (41,844 shoulders) showed 52.7% male, 60-69 yrs of age most prevalent (~38%) and 8.38% revision rate. Revision risk factors were increasing age, male sex, smoking, obesity, hyperlipidemia and vitamin D deficiency. Arthroscopy
Topics:
Orthobiologics
Continue Reading
